Updates are available Correction dated 2025-05-21
Click to view Correction: https://doi.org/10.1038/s41408-025-01306-9
-
Authors
Fiskus, Warren https://orcid.org/0000-0002-7343-6214
Mill, Christopher P. https://orcid.org/0000-0003-0957-6009
Birdwell, Christine
Davis, John A.
Das, Kaberi
Boettcher, Steffen https://orcid.org/0000-0001-9937-0957
Kadia, Tapan M. https://orcid.org/0000-0002-9892-9832
DiNardo, Courtney D. https://orcid.org/0000-0001-9003-0390
Takahashi, Koichi https://orcid.org/0000-0002-8027-9659
Loghavi, Sanam https://orcid.org/0000-0001-8980-3202
Soth, Michael J.
Heffernan, Tim
McGeehan, Gerard M.
Ruan, Xinjia
Su, Xiaoping
Vakoc, Christopher R.
Daver, Naval https://orcid.org/0000-0001-7103-373X
Bhalla, Kapil N. https://orcid.org/0000-0001-5209-5126
- License Information
-
More Information
Article History
Received: 16 February 2023
Revised: 29 March 2023
Accepted: 3 April 2023
First Online: 13 April 2023
Change Date: 15 May 2025
Change Type: Update
Change Details: The original online version of this article was revised: In this article fig. 1 has been updated. An incorrect Western blot for PBX3 was inadvertently used during the preparation of the figure.
Change Date: 21 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41408-025-01306-9
Competing interests
: GMM is an employee of Syndax Pharmaceuticals. KNB has received research funding from Iterion, Foghorn, and Nurix Pharmaceuticals, and he serves as a consultant for Iterion Therapeutics, none of which are directly related to the content of this paper. All other authors declare they have no conflict of interests to disclose.
